Fourpath Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $751K | Sell |
6,778
-3,645
| -35% | -$404K | 0.12% | 109 |
|
|
2025
Q1 | $1.17M | Sell |
10,423
-2,847
| -21% | -$319K | 0.2% | 84 |
|
|
2024
Q4 | $1.23M | Sell |
13,270
-1,874
| -12% | -$173K | 0.23% | 83 |
|
|
2024
Q3 | $1.27M | Buy |
15,144
+2,407
| +19% | +$202K | 0.23% | 82 |
|
|
2024
Q2 | $874K | Buy |
12,737
+1,644
| +15% | +$113K | 0.65% | 29 |
|
|
2024
Q1 | $813K | Buy |
11,093
+4,563
| +70% | +$334K | 0.56% | 37 |
|
|
2023
Q4 | $529K | Sell |
6,530
-210
| -3% | -$17K | 0.36% | 61 |
|
|
2023
Q3 | $505K | Buy |
6,740
+1,081
| +19% | +$81K | 0.38% | 65 |
|
|
2023
Q2 | $436K | Sell |
5,659
-3,523
| -38% | -$272K | 0.53% | 58 |
|
|
2023
Q1 | $762K | Sell |
9,182
-8,422
| -48% | -$699K | 0.53% | 43 |
|
|
2022
Q4 | $1.51M | Sell |
17,604
-3,195
| -15% | -$274K | 1.1% | 18 |
|
|
2022
Q3 | $1.28M | Buy |
20,799
+15
| +0.1% | +$925 | 0.88% | 24 |
|
|
2022
Q2 | $1.29M | Buy |
20,784
+2,739
| +15% | +$169K | 0.8% | 23 |
|
|
2022
Q1 | $1.07M | Buy |
18,045
+3,035
| +20% | +$180K | 0.43% | 41 |
|
|
2021
Q4 | $1.09M | Buy |
+15,010
| New | +$1.09M | 0.42% | 43 |
|